Tablets could make treatment more mainstream, with sector predicted to be worth $200bn by end of the decade ...

Abstract: In this paper, a novel model under false data injection (FDI) attack and measurement loss is established, and it is combined with lattice Kalman filter (LKF). LKF based on loss and ...

Semaglutide is used for the treatment of adults with insufficiently controlled type 2 diabetes mellitus and chronic weight management.

Aimee Donnellan has been a correspondent for Reuters since 2017. Her patch includes the pharmaceutical industry. Off the Scales is her first book. In brisk and breezy terms, it recounts the history ...

Gina Roberts folds up blankets on her bed in the sober home where she’s been living in Providence, R.I. on Feb. 2. She has ...

GoodRx reports that the FDA has approved oral semaglutide (Wegovy) for weight loss, offering an alternative to injections ...

Once-weekly CagriSema significantly reduced HbA1c and body weight vs semaglutide in patients with type 2 diabetes in the REIMAGINE 2 trial.

The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic ...

Biomed Industries, Inc. Announces Two NA-931 Phase 3 Trials, Targeting Durable Weight Loss & Lean-Mass Preservation ...

The Danish drugmaker kicked off 2026 with its explosive obesity pill launch, but recent challenges have centered around ...

Ozempic users tolerate severe nausea, vomiting, as long as weight loss continues, new study finds. When results stop, so does ...

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...